Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria
- 31 October 1996
- journal article
- Published by Elsevier BV in Parasitology Today
- Vol. 12 (10), 399-401
- https://doi.org/10.1016/0169-4758(96)10055-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Clinical Studies of Atovaquone, Alone or in Combination with other Antimalarial Drugs, for Treatment of Acute Uncomplicated Malaria in ThailandThe American Journal of Tropical Medicine and Hygiene, 1996
- Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malariaThe Lancet, 1993
- Fast emergence of Plasmodium falciparum resistance to halofantrineThe Lancet, 1993
- QinghaosuThe Lancet, 1993
- Antimalarial drug resistance: the pace quickensJournal of Antimicrobial Chemotherapy, 1992
- Multi-Drug Resistant Falciparum Malaria in Cameroon in 1987–1988 II. Mefloquine Resistance Confirmed in Vivo and in Vitro and its Correlation with Quinine ResistanceThe American Journal of Tropical Medicine and Hygiene, 1992
- The development and spread of drug-resistant malariaParasitology Today, 1991
- Mefloquine-resistant falciparum malaria on the Thai-Burmese borderThe Lancet, 1991
- The epidemiology of drug-resistant malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?The Lancet, 1989